Guardant Health Inc [NASDAQ: GH] stock went on an upward path that rose over 6.91% on Monday, amounting to a one-week price increase of more than 10.25%.
Over the last 12 months, GH stock dropped by -8.36%. The one-year Guardant Health Inc stock forecast points to a potential upside of 7.76. The average equity rating for GH stock is currently 1.30, trading closer to a bullish pattern in the stock market.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The market cap for the stock reached $4.32 billion, with 121.63 million shares outstanding and 115.97 million shares in the current float. Compared to the average trading volume of 2.02M shares, GH stock reached a trading volume of 5031713 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on Guardant Health Inc [GH]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for GH shares is $38.25 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on GH stock is a recommendation set at 1.30. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Guggenheim have made an estimate for Guardant Health Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on June 28, 2024. While these analysts kept the previous recommendation, Jefferies raised their target price to Buy. The new note on the price target was released on June 03, 2024, representing the official price target for Guardant Health Inc stock. Previously, the target price had yet another raise to $28, while Craig Hallum analysts kept a Buy rating on GH stock.
The Average True Range (ATR) for Guardant Health Inc is set at 1.66, with the Price to Sales ratio for GH stock in the period of the last 12 months amounting to 7.15. The Price to Book ratio for the last quarter was 62.92, with the Price to Cash per share for the same quarter was set at 9.23.
GH Stock Performance Analysis:
Guardant Health Inc [GH] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 10.25. With this latest performance, GH shares gained by 21.45% in over the last four-week period, additionally plugging by 55.97% over the last 6 months – not to mention a drop of -8.36% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for GH stock in for the last two-week period is set at 68.69, with the RSI for the last a single of trading hit 72.51, and the three-weeks RSI is set at 66.50 for Guardant Health Inc [GH]. The present Moving Average for the last 50 days of trading for this stock 29.18, while it was recorded at 32.93 for the last single week of trading, and 24.24 for the last 200 days.
Insight into Guardant Health Inc Fundamentals:
Guardant Health Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 5.66 and a Current Ratio set at 5.95.
GH Stock EPS
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for GH. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Guardant Health Inc go to 29.20%.
Guardant Health Inc [GH] Institutonal Ownership Details
The top three institutional holders of GH stocks are: VANGUARD GROUP INC with ownership of 1.32 billion shares, which is approximately 8.5034%. BLACKROCK INC., holding 1.04 billion shares of the stock with an approximate value of $178.43 billion in GH stocks shares; and BERKSHIRE HATHAWAY INC, currently with $135.36 billion in GH stock with ownership which is approximately 5.1238%.
